PhysioCue Inc. logo — PhysioCue has developed a non-invasive hypertension therapy...

PhysioCue Inc.

PhysioCue has developed a non-invasive hypertension therapy device and a migraine and headache therapy device.

Founded 2014 United States San Jose, United States 6 employees Seed Biotechnology, Health Care +1

General Information

Company Name PhysioCue Inc.
Founded Year 2014
Location United States San Jose, United States
Employees 6
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with PhysioCue Inc.. To contact PhysioCue Inc., visit physiocue.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does PhysioCue Inc. compare?

A PDF of PhysioCue Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting PhysioCue Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About PhysioCue Inc.

PhysioCue is a biotechnology and healthcare startup founded in 2013, with a focus on developing non-invasive medical devices for hypertension and migraine relief. The company's products have undergone clinical trials and have demonstrated efficacy in lowering high blood pressure and alleviating migraine pain. PhysioCue's non-invasive devices utilize controlled cold therapy to activate the carotid artery baroreceptor reflex, offering a safe and user-friendly alternative to pharmaceuticals and surgical options. These solutions are designed to be free from the side effects commonly associated with anti-hypertensive medications. Additionally, the company is working on a wearable mobile health device to further expand its product portfolio. PhysioCue's recent milestone includes a Seed Round investment in 18 March 2019 led by AQAL Group. This investment signifies confidence in PhysioCue's innovative approach to addressing critical healthcare needs and its potential for positive impact in the biotechnology and healthcare industries. With its unique non-invasive therapies and focus on clinical validation, PhysioCue has positioned itself as an intriguing prospect for potential venture capital investment, offering an opportunity to support groundbreaking solutions in the medical field with promising market potential.

Taxonomy: non-invasive therapy, blood pressure relief, migraine/headache relief, clinical trials, controlled cold therapy, carotid artery baroreceptor reflex, anti-hypertensive treatment, user-friendly, wearable health device

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 1
AQAL Group
18 Mar 2019
Venture Round Undisclosed 1
TSVC
15 May 2016
Seed Round Undisclosed 3
TSVC, NewDo Venture +1
14 Apr 2014

PhysioCue Inc. Alternatives & Competitors

View All Alternatives
PhysioCue Inc. vs
PyrAmes
PyrAmes United States

Blood pressure monitoring reimagined

Series A
13 employees
Health Care, IT
PhysioCue Inc. vs
Autem Therapeutics
Autem Therapeutics United States

EM-Powering Cancer Care

Series A
16 employees
Biotechnology, Health Care
PhysioCue Inc. vs

Using cryotherapy to stabilize vulnerable plaque and reduce the risk of heart attack

Series B
25 employees
Biotechnology, Health Care

FAQ About PhysioCue Inc.

PhysioCue has developed a non-invasive hypertension therapy device and a migraine and headache therapy device.
PhysioCue Inc. was founded in 2014.
PhysioCue Inc. is headquartered in San Jose, United States.
PhysioCue Inc. operates in Biotechnology, Health Care and Medical Devices. Its work centres on non-invasive therapy, blood pressure relief, migraine/headache relief and clinical trials.
PhysioCue Inc. has approximately 6 employees.
PhysioCue Inc. has completed 3 funding rounds. The latest funding stage is Seed.
Top alternatives and competitors to PhysioCue Inc. include PyrAmes, Autem Therapeutics, CryoTherapeutics SA, Uscom, AVACEN Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PhysioCue Inc. and PyrAmes are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for PhysioCue Inc., https://bouncewatch.com/company/physiocue, updated 1 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes